Authors:
Address: Department of Rehabilitation and Geriatrics, Geneva Medical School and University Hospitals, Chemin Pont Bochet, 3 Thonex-Geneve, CH 1226, Switzerland. Jean-Pierre.Michel@hcuge.ch
Journal:

Publication:

abstract

The high burden of infectious diseases in adults aged 60 years and older is disproportionate, considering that many of these diseases are vaccine-preventable. Based on careful analysis of the reasons for vaccination barriers/failures in the European population, the two European geriatric and gerontological societies (the European Union Geriatric Medicine Society [EUGMS] and the International Association of Gerontology and Geriatrics - European Region [IAGG-ER]) propose careful adaptation of current vaccine guidelines to promote preventive aspects, concerning both life threatening-diseases (influenza, pneumococcal pneumonia and tetanus/diphtheria) and diseases which adversely impact patients' quality of life (pertussis and herpes zoster). This consensus statement is designed to support official recommendations and improve the willingness to vaccinate the most rapidly growing segment of the population. The following guidelines are based on the importance of the sustainability of vaccine programs from midlife till extreme old age: - Promote healthy aging by optimizing health determinants of daily functions, active participation in society and individual quality of life; - Provide useful information to contribute toward harmonizing vaccine strategies at European level; - Support the public health, social and economic values of vaccination. Both healthcare professionals and consumers associations have a critical role to play in the implementation of such consensus clinical guidelines.

Related Articles
Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region.
Rejuvenation Res. 2009
Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region.
Michel JP, Chidiac C, Grubeck-Loebenstein B, Johnson RW, Lambert PH, Maggi S, Moulias R, Nicholson K, Werner H. Rejuvenation Res. 2009 Apr; 12(2):127-35.
Updated vaccine guidelines for aging and aged citizens of Europe.
Expert Rev Vaccines. 2010
Updated vaccine guidelines for aging and aged citizens of Europe.
Michel JP. Expert Rev Vaccines. 2010 Mar; 9(3 Suppl):7-10.
Review Silver paper: the future of health promotion and preventive actions, basic research, and clinical aspects of age-related disease--a report of the European Summit on Age-Related Disease.
Aging Clin Exp Res. 2009
Review Silver paper: the future of health promotion and preventive actions, basic research, and clinical aspects of age-related disease--a report of the European Summit on Age-Related Disease.
Cruz-Jentoft AJ, Franco A, Sommer P, Baeyens JP, Jankowska E, Maggi A, Ponikowski P, Rys A, Szczerbinska K, Michel JP, et al. Aging Clin Exp Res. 2009 Dec; 21(6):376-85.
[Vaccination: a programme for the whole life].
Rev Med Suisse. 2010
[Vaccination: a programme for the whole life].
Lang PO, Michel JP. Rev Med Suisse. 2010 Nov 10; 6(270):2118-24.
Review Vaccines for older adults.
Consult Pharm. 2009
Review Vaccines for older adults.
Lam S, Jodlowski TZ. Consult Pharm. 2009 May; 24(5):380-91.

To top • Home

---

Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer • webmaster